Back to Search
Norethindrone And Ethinyl Estradiol (7/14)
by Watson Laboratories IncContraceptionCOCP
DiscontinuedGeneric

Estrogen

Ethinyl Estradiol

0.035Mg,0.035Mg

Progestin

Norethindrone

0.5Mg,1Mg

Regimen Protocol

Biphasic 28 day

Androgenicity

Moderate

Approval Date

9/24/1991

Additives
None
Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc

Norethindrone And Ethinyl Estradiol (10/11)

Have clinical questions about Norethindrone And Ethinyl Estradiol (7/14)?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy